Navigation Links
Abaxis Reports Financial Performance With Record Sales for the Third Quarter of Fiscal 2011
Date:1/27/2011

nt sales were 1,261 units, up 4 percent over the same period last year.  Revenues from consumables, which include reagent discs, hematology reagent kits, VSpro coagulation and specialty cartridges, i-STAT cartridges and heartworm rapid tests, increased by an aggregate of $4.4 million, or 22 percent, over the same period last year.  Abaxis reported net income of $3.8 million for the fiscal quarter ended December 31, 2010, compared to $3.4 million for the same period last year.  Abaxis' effective tax rate in the quarter ended December 31, 2010 was 35 percent, compared to 37 percent for the same period last year.  Abaxis reported diluted net income per share of $0.17 (calculated based on 22,872,000 shares) for the three-month period ended December 31, 2010, compared to $0.15 per share (calculated based on 22,617,000 shares) for the same period last year.

Nine-Month Results:  For the nine-month period ended December 31, 2010, Abaxis reported revenues of $106.1 million, as compared with revenues of $90.9 million for the comparable period last year, an increase of 17 percent.  Revenues from instrument sales increased by an aggregate of $3.0 million, or 14 percent, over the same period last year.  Total medical and veterinary instrument sales were 3,274 units, up 10 percent over the same period last year.  Revenues from consumables increased by an aggregate of $13.1 million, or 21 percent, over the same period last year.  Abaxis reported net income of $11.2 million, compared to $10.4 million for the same period last year.  Abaxis' effective tax rate in the nine-month period ended December 31, 2010, was 38 percent, compared to 39 percent for the same period last year.  Abaxis reported diluted net income per share of $0.49 (calculated based on 22,795,000 shares) for the nine-month period ended December 31, 2010, compared to $0.46 per share (calculated based on 22,549,000 shares) for the same period l
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test
2. Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009
3. Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
4. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
5. Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Abaxis, Inc. to Present at Sidoti & Companys Ninth Annual West Coast Institutional Investor Forum
7. Abaxis to Report Second Quarter Fiscal 2011 Financial Results Tuesday, October 26, 2010
8. Abaxis Reports Financial Performance with Record Sales for the Second Quarter of Fiscal 2011
9. Abaxis, Inc. to Present at Stephens Fall Investment Conference
10. Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus
11. Abaxis to Report Third Quarter Fiscal 2011 Financial Results Thursday, January 27, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Unomedical Inc., a manufacturer of medical devices, today ... certain units of the single-patient use Manual Pulmonary Resuscitator ... 2002 - March 2008 and matching the lot numbers ... http://www.unomedical.com/?pageid=H3160 . This recall is being conducted ...
... a manufacturer of advanced cell imaging systems, today ... ImageStreamX imaging flow cytometers. The new instrument - ... - combines the speed, sensitivity, and phenotyping abilities ... feature set, and functional insights of microscopy. , ...
Cached Medicine Technology:Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators 2Amnis Begins Shipment of New ImageStreamX Imaging Flow Cytometers 2
(Date:1/22/2015)... 2015 The Incredible Bulk is a revolutionary ... increase lean muscle by up to 30lbs in less than ... of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... step-by-step, scientific diet formula that allows the body to pack ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... A study recently published in ... Medicine & Science in Sports & Exercise shows ... reduce gastrointestinal (GI) problems associated with physical strain ... the double-blind, placebo-controlled study took 10 grams of ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... 8 The National Business Group on Health, a non-profit ... that Sally Welborn, Senior Vice President of Benefits at Walmart, ... , "We are thrilled to announce Sally,s election to our ... President of Human Resources at Coca-Cola Enterprises Inc. and Chairman ...
... , ... Technologies, Inc. , has been selected by the Blue Cross ... watchlist screening software for OFAC, OIG and EPLS and USA PATRIOT ... compliance software to BCBSA,s Chicago headquarters and its member Blue Cross ...
... , - May Set Stage for Treating Brain Damage ... researchers have shown that feeding amino acids to brain-injured animals restores ... effective treatment for cognitive impairments suffered by people with traumatic brain ... intervention can restore a proper balance of neurochemicals in the injured ...
... levels increase, so does depression, anxiety and panic disorder, ... Young adults with elevated levels of lead in their ... and panic disorders, a new study suggests. , Researchers ... who took part in the U.S. National Health and ...
... is defined as the pathological retrograde movement of ... disturbances which may be important in reflux are ... motility disorder in these patients is ineffective esophageal ... have been shown to be strongly associated with ...
... is unclear whether patients with soft tissue sarcoma can ... type of therapy, some of the patient,s own (autologous) ... generally re-implanted after a course of high-dose chemotherapy. At ... benefit compared to conventional chemotherapy. Owing to current gaps ...
Cached Medicine News:Health News:National Business Group on Health Elects Sally Welborn, Walmart Executive, to Board of Directors 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3Health News:With Amino Acid Diet, Mice Improve After Brain Injury 2Health News:With Amino Acid Diet, Mice Improve After Brain Injury 3Health News:Lead Exposure May Affect Mental Health 2Health News:Are manometric findings different between the patients with erosive and nonerosive disease? 2Health News:Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy 2Health News:Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy 3Health News:Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy 4
... Optimal canal flare index. A/P and lateral ... rotational stability. Proximal medial hole, humeral / ... joint translation. Rough textured proximal surface to ... rotational resistance in cement, six stem sizes, ...
...
...
The AGC Revision Knee, extends the AGC Family to include implants for severe primary knees or revision. Provides rotational freedom of +/- 2 and varus/valgus freedom of +/- 1.5....
Medicine Products: